See all entries for this property (3 total)
Crystal system: monoclinic
| a: | 10.6322 (±0.0018) Å |
| b: | 11.617 (±0.002) Å |
| c: | 11.955 (±0.002) Å |
| α: | 90° |
| β: | 69.941 (±0.002)° |
| γ: | 90° |
Starting materials: PbBr2 (99.99%), Histamine (98%), HBr (40%)
Product: Pink crystals (yield: 40.3%)
Description: Equimolar amounts of PbBr2 (0.367g, 0.1 mmol) and histamine (0.113 g 0.1 mmol) were mixed in 10mL HBr by heating and refluxing at 90 °C and then, the solution slowly cooled to room temperature in N2 atmosphere.
Method: Single-crystal X-ray diffraction
Description: A Rigaku RAXIS-RAPID image plate diffractometer employed the ω-scan technique and used Mo Kα radiation (λ=0.71069 Å). Structures were solved via direct methods using SHELXS-97 and full-matrix least-squares techniques using SHELXL-97 implemented in WINGX.
Starting materials: PbBr2 (99.99%), Histamine (98%), HBr (40%), DMF
Product: Thin film on quartz substrate
Description: For preparing the crystals, equimolar amounts of PbBr2 (0.367g, 0.1 mmol) and histamine (0.113 g 0.1 mmol) were mixed in 10mL HBr by heating and refluxing at 90 °C and then, the solution slowly cooled to room temperature in N2 atmosphere. 10 mg of the obtained single crystals were dissolved into 1.5 mL dried DMF solution and then the solution was coated onto a quartz substrate. The spin cycle spent 1 s accelerating to 1200 rmp and then stayed at that rotation speed for 50 s. The substrate was then heated to 100 °C for 20 minutes.
Method: UV-Vis absorption
Description: A Hitachi F-4100 spectrofluorimeter was used to record the UV-Vis absorption spectra.
Starting materials: PbBr2 (99.99%), Histamine (98%), HBr (40%), DMF
Product: Thin film on quartz substrate
Description: For preparing the crystals, equimolar amounts of PbBr2 (0.367g, 0.1 mmol) and histamine (0.113 g 0.1 mmol) were mixed in 10mL HBr by heating and refluxing at 90 °C and then, the solution slowly cooled to room temperature in N2 atmosphere. 10 mg of the obtained single crystals were dissolved into 1.5 mL dried DMF solution and then the solution was coated onto a quartz substrate. The spin cycle spent 1 s accelerating to 1200 rmp and then stayed at that rotation speed for 50 s. The substrate was then heated to 100 °C for 20 minutes.
Method: Photoluminescence Spectroscopy
Description: A Hitachi F-4500 spectrofluorimeter was used for emission spectra. A 150 W xenon lamp was used as the excitation source.
Starting materials: PbCl2 (99.99%), Histamine (98%), HCl (36%), DMF
Product: Thin film on quartz substrate
Description: For preparing the crystals, equimolar amounts of PbCl2 (0.278g, 0.1 mmol) and histamine (0.113 g 0.1 mmol) were mixed in 10mL HCl by heating and refluxing at 90 °C and then, the solution slowly cooled to room temperature in N2 atmosphere. 10 mg of the obtained single crystals were dissolved into 1.5 mL dried DMF solution and then the solution was coated onto a quartz substrate. The spin cycle spent 1 s accelerating to 1200 rmp and then stayed at that rotation speed for 50 s. The substrate was then heated to 100 °C for 20 minutes.
Method: UV-Vis absorption
Description: A Hitachi F-4100 spectrofluorimeter was used to measure the UV-Vis absorption spectra.
Starting materials: bCl2 (99.99%), Histamine (98%), HCl (36%), DMF
Product: Thin film on quartz substrate
Description: For preparing the crystals, equimolar amounts of PbCl2 (0.278g, 0.1 mmol) and histamine (0.113 g 0.1 mmol) were mixed in 10mL HCl by heating and refluxing at 90 °C and then, the solution slowly cooled to room temperature in N2 atmosphere. 10 mg of the obtained single crystals were dissolved into 1.5 mL dried DMF solution and then the solution was coated onto a quartz substrate. The spin cycle spent 1 s accelerating to 1200 rmp and then stayed at that rotation speed for 50 s. The substrate was then heated to 100 °C for 20 minutes.
Method: Photoluminescence Spectroscopy
Description: A Hitachi F-4500 spectrofluorimeter was used for emission spectra. A 150 W xenon lamp was used as the excitation source.